This session will explore the rationale for combination therapy, patient selection considerations, safety monitoring, and sequencing of antifibrotic and immunomodulatory agents. Faculty will highlight real world case discussions that illustrate coordinated decision making across specialties. Emphasis will be placed on collaborative care models that align pulmonary and rheumatologic management to improve clinical outcomes and long term disease control.